Bell Biosystems, Inc. is a synthetic biology company based in San Francisco, CA. Our Magnelle® cell labeling and tracking platform is a living MRI contrast agent that allows researchers to perform longer-term in vivo imaging studies of viable cells for biodistribution and dose durability. Magnelle®-living contrast agents are derived from naturally occurring nonpathogenic bacteria and are transfected naturally into therapeutic cells without impacting phenotype.
953 Indiana Street
San Francisco, CA 94107